227 related articles for article (PubMed ID: 7545046)
1. Surface antigen analysis of group B Neisseria meningitis outer membrane by monoclonal antibodies: identification of bactericidal antibodies to class 5 protein.
Danelli MG; Batoreu NM; Lacerda MD; Ferreira CR; Cardoso JD; Peralta JM; Frasch CE
Curr Microbiol; 1995 Sep; 31(3):146-51. PubMed ID: 7545046
[TBL] [Abstract][Full Text] [Related]
2. Bactericidal activity of two IgG2a murine monoclonal antibodies with distinct fine specificities for group B Neisseria meningitidis capsular polysaccharide.
Hurpin CM; Carosella ED; Cazenave PA
Hybridoma; 1992 Dec; 11(6):677-87. PubMed ID: 1284118
[TBL] [Abstract][Full Text] [Related]
3. Human immune response to epitopes on the meningococcal outer membrane class 5 protein following natural infection.
Danelli MG; Alves CM; Bastos RC; Batoreu NM; Barroso DE; Peralta JM; Frasch CE
FEMS Immunol Med Microbiol; 1996 Sep; 15(2-3):159-68. PubMed ID: 8880142
[TBL] [Abstract][Full Text] [Related]
4. Functional activities and epitope specificity of human and murine antibodies against the class 4 outer membrane protein (Rmp) of Neisseria meningitidis.
Rosenqvist E; Musacchio A; Aase A; Høiby EA; Namork E; Kolberg J; Wedege E; Delvig A; Dalseg R; Michaelsen TE; Tommassen J
Infect Immun; 1999 Mar; 67(3):1267-76. PubMed ID: 10024570
[TBL] [Abstract][Full Text] [Related]
5. Mapping of monoclonal antibodies specific to P64k: a common antigen of several isolates of Neisseria meningitidis.
Nazábal C; Carmenate T; Cruz S; González S; Silva R; Musacchio A; Delgado M; Chinea G
Can J Microbiol; 2001 Feb; 47(2):158-64. PubMed ID: 11261496
[TBL] [Abstract][Full Text] [Related]
6. Use of transformation to construct antigenic hybrids of the class 1 outer membrane protein in Neisseria meningitidis.
van der Ley P; van der Biezen J; Hohenstein P; Peeters C; Poolman JT
Infect Immun; 1993 Oct; 61(10):4217-24. PubMed ID: 7691745
[TBL] [Abstract][Full Text] [Related]
7. N-Propionylated group B meningococcal polysaccharide mimics a unique bactericidal capsular epitope in group B Neisseria meningitidis.
Pon RA; Lussier M; Yang QL; Jennings HJ
J Exp Med; 1997 Jun; 185(11):1929-38. PubMed ID: 9166422
[TBL] [Abstract][Full Text] [Related]
8. Immunization with a multiple antigen peptide containing defined B- and T-cell epitopes: production of bactericidal antibodies against group B Neisseria meningitidis.
Christodoulides M; Heckels JE
Microbiology (Reading); 1994 Nov; 140 ( Pt 11)():2951-60. PubMed ID: 7529096
[TBL] [Abstract][Full Text] [Related]
9. The capsular polysaccharide of group B Neisseria meningitidis as a vehicle for vaccine development.
Jennings HJ
Contrib Microbiol Immunol; 1989; 10():151-65. PubMed ID: 2479499
[No Abstract] [Full Text] [Related]
10. Immunization with synthetic peptides containing epitopes of the class 1 outer-membrane protein of Neisseria meningitidis: production of bactericidal antibodies on immunization with a cyclic peptide.
Christodoulides M; McGuinness BT; Heckels JE
J Gen Microbiol; 1993 Aug; 139(8):1729-38. PubMed ID: 7691983
[TBL] [Abstract][Full Text] [Related]
11. Blocking of bactericidal killing of Neisseria meningitidis by antibodies directed against class 4 outer membrane protein.
Munkley A; Tinsley CR; Virji M; Heckels JE
Microb Pathog; 1991 Dec; 11(6):447-52. PubMed ID: 1795633
[TBL] [Abstract][Full Text] [Related]
12. Nonbactericidal antibodies against Neisseria gonorrhoeae: evaluation of their blocking effect on bactericidal antibodies directed against outer membrane antigens.
Virji M; Heckels JE
J Gen Microbiol; 1988 Oct; 134(10):2703-11. PubMed ID: 2474627
[TBL] [Abstract][Full Text] [Related]
13. Expression of class 5 antigens by meningococcal strains obtained from patients in Brazil and evaluation of two new monoclonal antibodies.
De Gaspari E; Zollinger W
Braz J Infect Dis; 2001 Jun; 5(3):143-53. PubMed ID: 11506778
[TBL] [Abstract][Full Text] [Related]
14. A linear B-cell epitope on the class 3 outer-membrane protein of Neisseria meningitidis recognized after vaccination with the Norwegian group B outer-membrane vesicle vaccine.
Delvig AA; Wedege E; Caugant DA; Dalseg R; Kolberg J; Achtman M; Rosenqvist E
Microbiology (Reading); 1995 Jul; 141 ( Pt 7)():1593-600. PubMed ID: 7551027
[TBL] [Abstract][Full Text] [Related]
15. Synergic complement-mediated bactericidal activity of monoclonal antibodies with distinct specificity.
Natali EN; Principato S; Ferlicca F; Bianchi F; Fontana LE; Faleri A; Pansegrau W; Surdo PL; Bartolini E; Santini L; Brunelli B; Giusti F; Veggi D; Ferlenghi I; Norais N; Scarselli M
FASEB J; 2020 Aug; 34(8):10329-10341. PubMed ID: 32725956
[TBL] [Abstract][Full Text] [Related]
16. Shielding of immunogenic domains in Neisseria meningitidis FrpB (FetA) by the major variable region.
Kortekaas J; Pettersson A; van der Biezen J; Weynants VE; van der Ley P; Poolman J; Bos MP; Tommassen J
Vaccine; 2007 Jan; 25(1):72-84. PubMed ID: 16914236
[TBL] [Abstract][Full Text] [Related]
17. Class-specific human bactericidal antibodies to capsular and noncapsular surface antigens of Neisseria meningitidis.
Skevakis L; Frasch CE; Zahradnik JM; Dolin R
J Infect Dis; 1984 Mar; 149(3):387-96. PubMed ID: 6425422
[TBL] [Abstract][Full Text] [Related]
18. Functional activity of anti-Neisserial surface protein A monoclonal antibodies against strains of Neisseria meningitidis serogroup B.
Moe GR; Zuno-Mitchell P; Lee SS; Lucas AH; Granoff DM
Infect Immun; 2001 Jun; 69(6):3762-71. PubMed ID: 11349041
[TBL] [Abstract][Full Text] [Related]
19. Location of a blocking epitope on outer-membrane protein III of Neisseria gonorrhoeae by synthetic peptide analysis.
Virji M; Heckels JE
J Gen Microbiol; 1989 Jul; 135(7):1895-9. PubMed ID: 2482335
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of the serotype b and species-specific antigens of Actinobacillus actinobacillus actinomycetemcomitans recognized by monoclonal antibodies.
McArthur WP; Stroup S; McClellan S; Leung KP
Oral Microbiol Immunol; 1996 Aug; 11(4):209-19. PubMed ID: 9002872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
